Atlas Trials

Docosahexaenoic Acid (DHA) Supplementation During Pregnancy Reduces the Risk of Preterm Birth in Threatened Preterm Labor

Clinical trial NCT06302023 · COMPLETED

Trial details

NCT number
NCT06302023
Sponsor
Khon Kaen University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pregnant Women Diagnosed With Threatened Preterm Labor
Start date
2024-04-01
Primary completion
2024-10-07
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.